Preprint
Brief Report

This version is not peer-reviewed.

Considerations About Melanocytic Nevi

Submitted:

23 January 2025

Posted:

24 January 2025

Read the latest preprint version here

Abstract
The purpose of the study is to analyse and to identify specific structural characteristics of melanocytic nevi, to youth pacients. Using the optical and electronic microscope, could be possible a proper describtion related melanocytic nevi. In this study play a significant role, different factors, such as genetic, epigenetic, microbiomic and proteomic factors. Disease diagnostic management and future trends, directions are also important key points As future directions good to mention preventive and prophylactic methods.
Keywords: 
;  ;  ;  ;  

Introduction

In order to define a disease, must have in attention a lot of differents factors such as historical points, or social and cultural.. Results of research studies, show us that some connective cells such as fibroblasts, lose their identity, in pathological conditions. [1] Another specific cells, namely melanocytes are known that having a specific structural point that is consider important in structural pathological description. [2] Refering to melanocytic nevi, in medical specific field of study and of research, various pigmented lesions of the epiderm, known as nevi, could be observe in different pars of the body. [3] For a proper diagnostic, an atypical nevus,can be biopsied.[4] In this direction, is important to practice a biopsy beside the extended clinical evaluation in melanocytic nevi A great point in this field of research, could be possible the genetic susceptibility for morphological and functional alterations, in nevi with that surrounding nevi changes. [5] A complete medical examination, play a great point for establishing the medical conduct, for a healthy status improving.[6,7] Structural analysis describe specific cells namely melanocytes as aggregated in ‘nests’, which conduct forming the nevus cells.[8] To the youth patients researchers found specific cells knowing as melanocytes. This specific cells could be found in areas of the epiderm of the parts of the body. [9,10] Theoretical and practical studies, show that melanocytic nevi developing in utero present genetical differences from those that appear later.[11,12] In the present field, we can mention about various informations from scientific literature, referring to specific nevi. [13] Also from literature and from practicum actually are known different scientific informatiuons about extending melanocytic nevi, having specific scientific names.[14] Because are many cases in all of the world, diagnosed as melanocitic nevi, we can mention that currently, the proper treatment of epidermal nevi is challenging. [15,16,17,18]Congenital melanocytic nevi it is known as a subject of research that offer controversy. [19] Clinical monitoring in congenital melanocytic nevi is important for diagnosis and for possible medical treatment strategies applications. [20] A complete examination of the human body, during a medical examination, is important. [21,22] Best to mention that the nowadays higher incidence in melanoma is in acompaniament of the nevi existence of the body and of the increase exposure to the ultraviolet light. [23,24] Practical biopsy is important for diagnosis.[25]One of an important point in the diagnosis of melanocytic nevi is to differentiate melanocitic nevi from a possible melanoma. [26,27] . An earlier diagnosis of the melanoma play a great role in idea that neoplasic lessions could be develop from pre-existing nevi in many cases. [28] Unfortunately, the epidermal melanoma is growing faster., depending of various conditions. [29,30]

Melanocytic Nevi an Approach

From many types of nevi, in the next short written text, we will describe a little bit on Ito’s nevus and Ota’s nevus. This two types of nevi, could be observe in pregnancy, at birdh and also to puberty. Them presence is in concordance with hormonal changes. Research studies described possibles malignant status in Ota’s nevus, rarely in Ito’s nevus. [31,32]This twoo previously mentioned types of nevi, namely Ito and Ota, do not differ from histologically point of view. Ito’s nevus and Ota’s nevus are distinguished by specific location on the body. So, tipically,Ito nevus occurs in the arm region and Ota nevus could be find on the face. [33,34]Ota’s nevus could also found in the supply areas of the first two branches of the trigeminal nerve. [34,35,36,37] Structurally, Ito’s nevus presents as a slate-blue/gray-blue macula in the shoulder/breast and lateral arm region in the supply area of the brachial nerve, in infants or prior puberty.[38] It is know that a specific sign of melanoma within the existing Ito’s nevus as a typical nodule. [39] In rarely malignancy cases in patients diagnosed with Ito’s nevi have been reported in adition, tipical nodules.[40,41]
From birth age, congenital melanocytic nevi (CMN) it is know as one of the frequent skin lesion. [42] From research results and conclusions, could be find rarely medical namely,neuroid differentiation. To a specific analyse, is possible to observe specific areas of cells with myxoid stroma in adition. Possible resemble later than, as neurofibromas.[42]
From a curently research pespective we can mention that in utero, specific stem cells from the neuroectoderm play a signifiant role such as migration to the skin as melanoblasts. Mechanism refers to a differentiate process into melanocytes. In addition, mutations arising in specific cells can occur to well known mosaicisms. Good to know that in the early embryogenesis, multipotent progenitor cells can be affected, leading to the presence of multiple congenital melanocytic nevi and also to extracutaneous alterations..[43,44]
In adition to previously above metioned idea, congenital melanocytic nevi occur as a result of in-utero somatic mutations. In this idea, genes play a great role. So there are know the mitogen-activated protein kinase (MAPK) pathway (mainly NRAS and BRAF). More than,their specific mutations refers to damages in the development of cutaneous and/or extracutaneous previously mentioned mosaicisms.[45] Aditionally to congenital melanocytic nevi, proliferative nodules (PN) constitute nodular lesions. [46] All described epidermal alterations, arel factors incriminate in differentiating proliferative nodule from melanoma.(Figure 1a,b)
Good to menton that neurocutaneous melanosis is a disease where congenital melanocytic nevi are associated with melanocyte proliferation. Beside, satellite lesions are especially at risk. Clinically are signs and specific symptoms So could be descibe neurological symptoms,with possible intracranial pressure.[47]

Material and Methods

For the purpose of the study we can mention about classic laboratory technique used and about the materials needed. In the specific laboratory, were followed the steps of the classic method, using Hematoxylin &Eosin staining. The samples used were from male and female youth patients, before mature age, from urban and rural residence. This are examined by performing the optical microscopic analysis. The operative pieces are intended to bring in the pathological anatomy service for macroscopic examination for diagnostic purposes

Results

Epiderm protect us during the life, from different factors. For a morphological analyse, structural and ultrastructural characteristics could be describes, using optical and electron microscope. Structural analyse of the epiderm, using colour laboratory techniques, is able to describe the specific layers with their characteristics. More than, using electron microscope, specific compounds as filaggrin which is knowing as an important epidermal protein and/or tight junction located in the granular layer of the epiderm, could be observed. For this purpose, transmission electron microscope examination, is consider one proper method for analyse. Scanning electron microscopy is also a modern method for analyse, which offer results that demonstrate abnormalities in the epiderm ultrastructure. (Figure 2)
The human body is covers by skin and the epiderm contein differents types of glands, as sebaceous glands and sudoripar glands. In this study direction, it is known a typical physiopathlogic mechanism for the functionality of the body, including epidermal compounds and their body sorroundings. Histopathological analyse describe various modifications to the melanocytic nevi aspect, located on various regions of the body. So we can mention asymmetry, irregular form, cytologic atypia, and mitotic activity. Medical specialists, describe and conclude that to benign melanocytic nevi, could be possible a describtion for atypical pathological characteristics of nevi and more important to mention characteristics when benign nevi are traumatized.(Figure 3)
Epiderm is a barrier, but is able for conducing to an illness status if include modifications in structural compounds. Histopathological analyse describe the melanocytic nevi located on various regions of the body,with asymmetry, irregular form, cytologic atypia and mitotic activity. More than, medical specialists, describe and conclude related to the structural aspects in benign traumatized melanocytic nevi. In this field, dermoscopy play a role for a proper diagnostic. Dermoscopy play a role for a proper diagnostic important in practice to all ages, including, youth age and children.

Discussions

Great interest in knowing epidermal compounds. So, the epiderm, is composed of a number of specific lyers. Specific cells are known. One of the role of the epiderm is implication in differents injuries. Alterations in the compunds of the epiderm layers, contribute to the visual signs of pathologic conditions. One research direction, refer to the role of benign melanocytic lesions with alterations, which conduct to malignant cutanat melanoma. Related to melanocytic nevi, in some circumstances, could be possible that the prognosis be poor having in attention the healthy of the patients having comorbidities. Pathological analyse and diagnosis reffering to melanocytic nevi located on differents regions from the body can find asymmetry, irregularity, cytologic atypia, and mitotic activity. Medical team including dermatologists, pathologists and dermatopathologists play a great role, in idea reffering to differentiate benign melanocytic nevi from malignant melanoma. This is important in order to avoid unnecessary surgical intervention or a treatment.

Conclusions

Techniques for the laboratory diagnosis, as a key point in monitoring pathological status to patients diagnosed with melanocytic nevi, conduct to a proper quality of life. Implication of an interprofessional team is a condition that play a great medical role. Congenital melanocytic nevi are pigmented lesions that are usually present a birth. They are generally benign, but a small percentage (especially the larger ones) can potentially transform into malignant melanoma.Future trends, new laboratory methods and techniques for diagnosis. are in attention, for the next coming period of time.

References

  1. Salzer, M.C.; Lafzi, A.; Berenguer-Llergo, A.; Youssif, C.; Castellanos, A.; Solanas, G.; Peixoto, F.O.; Stephan-Otto Attolini, C.; Prats, N.; Aguilera, M.; Martín-Caballero, J.; Heyn, H.; Benitah, S.A. Identity noise and adipogenic traits characterize dermal fibroblast aging. Cell. 2018, 175, 1575–1590e22. [Google Scholar] [CrossRef] [PubMed]
  2. Palicka, G.A.; Rhodes, A.R. Acral melanocytic nevi: prevalence and distribution of gross morphologic features in white and black adults. Arch Dermatol. 2010, 146, 1085–94. [Google Scholar] [CrossRef] [PubMed]
  3. Wang, M.; Xu, Y.; Wang, J.; Cui, L.; Wang, J.; Hu, X.B.; Jiang, H.Q.; Hong, Z.J.; Yuan, S.M. Surgical Management of Plantar Melanoma: A Retrospective Study in One Center. J Foot Ankle Surg. 2018, 57, 689–693. [Google Scholar] [CrossRef] [PubMed]
  4. Richtig, E. ASCO Congress 2018: melanoma treatment. Memo. 2018, 11, 261–265. [Google Scholar] [CrossRef]
  5. Wang, B.; Qu, X.L.; Chen, Y. Identification of the potential prognostic genes of human melanoma. J Cell Physiol. 2019, 234, 9810–9815. [Google Scholar] [CrossRef]
  6. Bristow, I.; Bower, C. Melanoma of the Foot. Clin Podiatr Med Surg. 2016, 33, 409–22. [Google Scholar] [CrossRef]
  7. Lallas, A.; Kyrgidis, A.; Koga, H.; Moscarella, E.; Tschandl, P.; Apalla, Z.; Di Stefani, A.; Ioannides, D.; Kittler, H.; Kobayashi, K.; Lazaridou, E.; Longo, C.; Phan, A.; Saida, T.; Tanaka, M.; Thomas, L.; Zalaudek, I.; Argenziano, G. The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma. Br J Dermatol. 2015, 173, 1041–9. [Google Scholar] [CrossRef]
  8. Tronnier, M. Melanotische Flecke und melanozytäre Nävi. In: Plewig G, Ruzicka T, Kaufmann R, Hertl M. Braun-Falcos Dermatol. Venerol. Allergol. Springer Berlin Heidelberg, 7. Auflage, 2016.
  9. Tolleson, W.H. Human Melanocyte Biology, Toxicology, and Pathology. J Environ Sci Health Part C 2005, 23, 105–61. [Google Scholar] [CrossRef]
  10. Thomas, A.J.; Erickson, C.A. The making of a melanocyte: the specification of melanoblasts from the neural crest. Pigment Cell Melanoma Res 2008, 21, 598–610. [Google Scholar] [CrossRef]
  11. Colebatch, A.J.; Ferguson, P.; Newell, F.; et al. Molecular genomic profiling of melanocytic nevi. J Invest Dermatol 2019, 139, 1762–8. [Google Scholar] [CrossRef]
  12. Kinsler, V.A.; Thomas, A.C.; Ishida, M.; et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 2013, 133, 2229–36. [Google Scholar] [CrossRef] [PubMed]
  13. Bandyopadhyay, D. Halo nevus. Indian Pediatr 2014, 51, 850. [Google Scholar]
  14. Fernandez-Flores, A. Eponyms, Morphology, and Pathogenesis of some less mentioned types of melanocytic nevi. Am J Dermatopathol 2012, 34, 607–18. [Google Scholar] [CrossRef] [PubMed]
  15. Kim, J.J. (Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA), Chang MW, Shwayder T. Topical tre-tinoin and 5-fluorouracil in the treatment of linear verrucous epidermal nevus. J Am Acad Dermatol. 2000, 43 Pt 1, 129–132. [Google Scholar] [CrossRef]
  16. Brown, H.M.; Gorlin, R.J. Oral mucosal involvement in nevus unius lateris (Icthyosis Hysterix). Arch Dermatol. 1960, 81, 509–515. [Google Scholar] [CrossRef] [PubMed]
  17. Zvulunov, A. (Soroka Medical Center, Ben-Gurion University, Beer-Sheva Israel), Grunwald, M.H.; Halvy, S. Topical calcipotriol for treatment of infammatory linear verrucous epidermal nevus. Arch Dermatol. 1997, 133, 567–568. [Google Scholar] [CrossRef] [PubMed]
  18. Boyce, S. (Washington Institute of Dermatologic Laser Surgery, Washington, DC 20037, USA), Alster T. CO2 laser treatment of epidermal nevi: Long-term success. Dermatol Surg. 2002, 28, 611–614. [Google Scholar]
  19. Arad Ehud, Zuker M. Ronald, The shifting paradigm in the management of giant congenital melanocytic nevi: review and clinical applications. Plast Reconstr Surg. 2014, 133, 367–376. [CrossRef]
  20. Mologousis, M.A.; Tsai, S.Y.; Tissera, K.A.; Levin, Y.S.; Hawryluk, E.B. , Updates in the Management of Congenital Melanocytic Nevi. Children (Basel). 2024, 11, 62. [Google Scholar] [CrossRef]
  21. Bristow I, Bower C. Melanoma of the Foot. Clin Podiatr Med Surg. 2016, 33, 409–22.
  22. Lallas, A.; Kyrgidis, A.; Koga, H.; Moscarella, E.; Tschandl, P.; Apalla, Z.; Di Stefani, A.; Ioannides, D.; Kittler, H.; Kobayashi, K.; Lazaridou, E.; Longo, C.; Phan, A.; Saida, T.; Tanaka, M.; Thomas, L.; Zalaudek, I.; Argenziano, G. The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma. Br J Dermatol. 2015, 173, 1041–9. [Google Scholar] [CrossRef] [PubMed]
  23. Bartoš, V.; Kullová, M. Malignant Melanomas of the Skin Arising on the Feet. Klin Onkol. 2018, 31, 289–292. [Google Scholar] [CrossRef] [PubMed]
  24. Palicka, G.A.; Rhodes, A.R. Acral melanocytic nevi: prevalence and distribution of gross morphologic features in white and black adults. Arch Dermatol. 2010, 146, 1085–94. [Google Scholar] [CrossRef] [PubMed]
  25. Bristow, I.R.; de Berker, D.A.; Acland, K.M.; Turner, R.J.; Bowling, J. Clinical guidelines for the recognition of melanoma of the foot and nail unit. J Foot Ankle Res. 2010, 3, 25. [Google Scholar] [CrossRef]
  26. Gershenwald, J.E.; Ross, M.I. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med. 2011, 364, 1738–45. [Google Scholar] [CrossRef]
  27. Eggermont, A.M.; Spatz, A.; Robert, C. Cutaneous melanoma. Lancet. 2014, 383, 816–27. [Google Scholar] [CrossRef]
  28. Elder, D.E. Precursors to melanoma and their mimics: nevi of special sites. Mod Pathol. 2006, 19 (Suppl. S2), S4–20. [Google Scholar] [CrossRef]
  29. Gershenwald, J.E.; Ross, M.I. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med. 2011, 364, 1738–45. [Google Scholar] [CrossRef]
  30. Eggermont, A.M.; Spatz, A.; Robert, C. Cutaneous melanoma. Lancet. 2014, 383, 816–27. [Google Scholar] [CrossRef]
  31. van Krieken, J.H.; Boom, B.W.; Scheffer, E. Malignant transformation in a naevus of Ito. A case report. Histopathology 1988, 12, 100–2. [Google Scholar]
  32. Wise, S.R.; Capra, G.; Martin, P.; et al. Malignant melanoma transformation within a nevus of Ito. J Am Acad Dermatol 2010, 62, 869–74. [Google Scholar] [CrossRef] [PubMed]
  33. Pérez, M.E.; Bley, C.; Cárdenas, C. Nevus of Ota, a classic presentation. Med Clin (Barc) 2019, 153, 92. [Google Scholar] [CrossRef] [PubMed]
  34. Agarwal, P.; Patel, B.C. Nevus of Ota and Ito. StatPearls 2020.
  35. Kang, H.Y.; Kang, W.H. Bilateral type of nevus of Ota presenting as agminated lentigines. Eur J Dermatol EJD 2003, 13, 205–6. [Google Scholar]
  36. Turnbull, J.R.; Assaf, C.; Zouboulis, C.; Tebbe, B. Bilateral naevus of Ota: a rare manifestation in a Caucasian. J Eur Acad Dermatol Venereol JEADV 2004, 18, 353–5. [Google Scholar] [CrossRef]
  37. Hori, Y.; Kawashima, M.; Oohara, K.; Kukita, A. Acquired, bilateral nevus of Ota-like macules. J Am Acad Dermatol 1984, 10, 961–4. [Google Scholar] [CrossRef]
  38. Que, S.K.T.; Weston, G.; Suchecki, J.; Ricketts, J. Pigmentary disorders of the eyes and skin. Clin Dermatol 2015, 33, 147–58. [Google Scholar] [CrossRef]
  39. Martínez-Peñuela, A.; Iglesias, M.E.; Mercado, M.R.; et al. Malignant transformation of a nevus of Ito: description of a rare case. Actas Dermosifiliogr 2011, 102, 817–20. [Google Scholar] [CrossRef]
  40. Wise, S.R.; Capra, G.; Martin, P.; et al. Malignant melanoma transformation within a nevus of Ito. J Am Acad Dermatol 2010, 62, 869–74. [Google Scholar] [CrossRef]
  41. Martínez-Peñuela, A.; Iglesias, M.E.; Mercado, M.R.; et al. Malignant transformation of a nevus of Ito: description of a rare case. Actas Dermosifiliogr 2011, 102, 817–20. [Google Scholar] [CrossRef]
  42. Zayour, M.; Lazova, R. Congenital melanocytic nevi. Clin Lab Med. 2011, 31, 267–80. [Google Scholar] [CrossRef] [PubMed]
  43. Schaffer, J.V. Update on melanocytic nevi in children. Clin Dermatol. 2015, 33, 368–86. [Google Scholar] [CrossRef] [PubMed]
  44. Kinsler, V.A.; O’Hare, P.; Bulstrode, N.; Calonje, J.E.; Chong, W.K.; Hargrave, D.; Jacques, T.; Lomas, D.; Sebire, N.J.; Slater, O. Melanoma in congenital melanocytic naevi. Br J Dermatol. 2017, 176, 1131–1143. [Google Scholar] [CrossRef] [PubMed]
  45. Price, H.N. Congenital melanocytic nevi: update in genetics and management. Curr Opin Pediatr. 2016, 28, 476–82. [Google Scholar] [CrossRef] [PubMed]
  46. Vergier, B.; Laharanne, E.; Prochazkova-Carlotti, M.; de la Fouchardière, A.; Merlio, J.P.; Kadlub, N.; Avril, M.F.; Bodemer, C.; Lacoste, C.; Boralevi, F.; Taieb, A.; Ezzedine, K.; Fraitag, S. Proliferative Nodules vs Melanoma Arising in Giant Congenital Melanocytic Nevi During Childhood. JAMA Dermatol. 2016, 152, 1147–1151. [Google Scholar] [CrossRef]
  47. Flores-Sarnat, L. Neurocutaneous melanocytosis. Handb Clin Neurol. 2013, 111, 369–88. [Google Scholar]
Figure 1. a. Congenital melanocytic nevi. Study objectives. b. Congenital melanocytic nevi. Study objectives.
Figure 1. a. Congenital melanocytic nevi. Study objectives. b. Congenital melanocytic nevi. Study objectives.
Preprints 147125 g001aPreprints 147125 g001b
Figure 2. Methods for epiderm analyse.
Figure 2. Methods for epiderm analyse.
Preprints 147125 g002
Figure 3. Changes in epidermal compounds - from normal to pathological.
Figure 3. Changes in epidermal compounds - from normal to pathological.
Preprints 147125 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2026 MDPI (Basel, Switzerland) unless otherwise stated